Reuters -- Takeda Pharmaceutical is looking to enter the fast-growing Indian drug market, but Japan's largest drugmaker is yet to decide whether it will do so on its own or through acquisition, a spokesman said on Wednesday. TheFinancial Express reported on Wednesday that Takeda had appointed Shankar Suryanarayanan, who had previously worked with Swiss drugmakers Roche (ROG.VX) and Novartis (NOVN.VX), as head of its India operations.
